Veterinary Medicines

Neotarchocin (360 mg + 250 mg)/g Granulat do sporządzania roztworu doustnego

Authorised
  • Oxytetracycline hydrochloride
  • NEOMYCIN SULFATE
Download as PDF

Product identification

Medicine name:
Neotarchocin (360 mg + 250 mg)/g Granulat do sporządzania roztworu doustnego
Active substance:
  • Oxytetracycline hydrochloride
  • NEOMYCIN SULFATE
Target species:
  • Pig
  • Chicken (hen)
  • Turkey
  • Cattle
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Oxytetracycline hydrochloride
    0.36
    gram(s)
    /
    1.00
    gram(s)
  • NEOMYCIN SULFATE
Pharmaceutical form:
  • Granules for oral solution
Withdrawal period by route of administration:
  • In drinking water use
    • Pig
      • Meat and offal
        21
        day
    • Chicken (hen)
      • Meat and offal
        14
        day
    • Turkey
      • Meat and offal
        14
        day
    • Cattle
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Biofaktor Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biofaktor Sp. z o.o.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1448
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."